Sun Pharma - Cardizem CD – Para IV For An Age Old Compound, Still Enjoys Limited Competition
As expected, Sun Pharma received the final approval for generic Cardizem CD (annual sales of $300m) for all the strengths, viz. 120 mg, 180 mg, 240 mg, 300 mg and 360 mg. The product, though very old, only has 3 generic players with just about 60% price erosion from the patented price. All the current generic companies including Sun pharma has settled the Para IV litigation with Valeant (erstwhile Biovail) and we expect no other generic player to enter till August 2012. Additionally, Sun is the only generic player for Cardizem CD 360 mg that accounts for ~$75m of sales.
COMPANIES MENTIONED
SUN PHARMA
SUN PHARMA
